koryu

editas medicine crispr/cas9 investment

Long
koryu Mis à jour   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


Transaction en cours:
nice start. also watching NTLA
Commentaire:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

Commentaire:
increasing position in this dip
Commentaire:
pitchfork scenario
Commentaire:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
Commentaire:
break out channel and horizontal resistance! <3
Commentaire:
EW
Commentaire:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
Commentaire:
HODL the double up :D

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.